Validity of endoscopic resection for clinically diagnosed T1a-MM/T1b-SM1 N0 M0 esophageal squamous cell carcinoma
- 21 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Esophagus
- Vol. 18 (3), 585-593
- https://doi.org/10.1007/s10388-021-00814-4
Abstract
Background Previous guidelines have not described clear recommendations for performing endoscopic resection (ER) of T1a-muscularis mucosa (MM)/T1b-submucosal (SM1) cancers that have invaded ≤ 200 μm because these are considered to have a non-negligible risk of metastasis based on previous analyses of pathologically diagnosed (p)MM/SM1 cancers. Considering that the indication for ER is determined based on a clinical diagnosis, the applicability of ER should be investigated in clinical (c)MM/SM1 but not pMM/SM1 cancers. This study aimed to evaluate validity of ER for cMM/SM1 cancers. Methods In total, 175 cMM/SM1 esophageal squamous cell carcinoma cases that were endoscopically or surgically resected between January 2008 and December 2018 were identified from a prospectively maintained database. We histologically evaluated resected specimens and divided them into low- (n = 92) and high-risk (n = 83) cancers for metastasis. Results Univariate analysis showed that longer tumor length and larger circumferential extent were significantly correlated with high-risk cancer (P < 0.001). Multivariate analysis showed that tumor circumference was an independent predictor of high-risk cancer (P = 0.036). The proportion of low-risk cancers among cases with ≤ 3/4, > 3/4 and < 1, and whole circumferential extent were 59, 17, and 14%, respectively, and the post-ER stricture rates of these groups were 12, 33, and 100%, respectively. Conclusion ER is the first-line treatment for cMM/SM1 cancers with ≤ 3/4 circumferential extent considering that 59% of cMM/SM1 cancers were low-risk cancers for which ER is mostly curative. ER is not recommended for whole circumferential cMM/SM1 cancers given the low proportion of low-risk cancers and the high risk of stricture after ER.Keywords
This publication has 29 references indexed in Scilit:
- Early Detection of Superficial Squamous Cell Carcinoma in the Head and Neck Region and Esophagus by Narrow Band Imaging: A Multicenter Randomized Controlled TrialJournal of Clinical Oncology, 2010
- A Phase II Trial of Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma: Japan Clinical Oncology Group Study (JCOG9708)Japanese Journal of Clinical Oncology, 2009
- Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinomaJournal of Gastroenterology and Hepatology, 2008
- Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae - a multicenter retrospective cohort studyEndoscopy, 2007
- Probe EUS for the diagnosis of invasion depth in superficial esophageal cancer: a comparison between a jelly-filled method and a water-filled balloon methodGastrointestinal Endoscopy, 2006
- Update on the Paris Classification of Superficial Neoplastic Lesions in the Digestive TractEndoscopy, 2005
- Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeperGastrointestinal Endoscopy, 2002
- Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeperGastrointestinal Endoscopy, 2002
- Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasisCancer, 2002
- Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesionsGastrointestinal Endoscopy, 1993